Effects of puerarin on gait disturbance in a 6-hydroxydopamine rodent model of Parkinson's disease

Author:

Kim Na-Hyun1,Goto Yukiori2,Lee Young-A1

Affiliation:

1. Daegu Catholic University

2. Kyoto University

Abstract

Abstract

Background Parkinson's disease (PD) is a neurodegenerative disorder caused by dopamine neuronal dysfunction. Although dopamine agonists and N-methyl-D-aspartate (NMDA) receptor antagonists are used to treat PD, chronic use causes severe side effects. Therefore, puerarin (PUE) affects the dopamine system and is a considerable candidate for PD; however, its therapeutic effects on PD-associated motor dysfunction remain unclear. Therefore, this study aimed to investigate the effects of PUE treatment on motor dysfunction in a 6-hydroxydopamine (6-OHDA) rodent PD model. Methods Adult male ICR mice received unilateral 6-OHDA microinfusion into the right medial forebrain bundle. After a 2-week recovery period, PUE (20 or 50 mg/kg) or the vehicle (saline, VEH) was intraperitoneally administered once daily for 3 weeks. Motor dysfunction was assessed using the locomotion, rotation, and gait cycle tests 2 weeks after PUE administration. Local field potential (LFP) was measured in the substantia nigra compacta (SNc), striatum (STR), subthalamic nucleus (STN), and primary motor cortex (M1). Results PD animals showed higher unidirectional rotation and abnormal gait cycle without locomotion change compared with sham surgery (control, CTR) animals. PUE treatment ameliorated the abnormal gait cycle of PD animals. These effects were different with DA agonist and NMDA receptor antagonist treatments. Moreover, PUE treatment induced no changes in attenuated LFPs of beta wave in the STR, STN, and M1, and coherence of delta wave between SNc-STN was shown in PD animals. Conclusions This study suggests that PUE is a beneficial co-therapeutic agent for alleviating gait disturbances via dopaminergic and non-dopaminergic neurocircuitry in PD.

Publisher

Springer Science and Business Media LLC

Reference59 articles.

1. Kouli A, Torsney KM, Kuan WL. Parkinson’s disease: Etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson’s disease: Pathogenesis and clinical aspects. Brisbane (AU). Codon; 2018.

2. The Parkinson pandemic-A call to action;Dorsey ER;JAMA Neurol,2018

3. Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson’s disease with dementia;Ho MWR;Sci Rep,2020

4. Severity of depressive and motor symptoms impacts quality of life in Parkinson’s disease patients at an academic movement clinic: A cross-sectional study;Lacy B;Clin Park Relat Disord,2023

5. A guide to the generation of a 6-hydroxydopamine mouse model of Parkinson’s disease for the study of non-motor symptoms;Masini D;Biomedicines,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3